Daily Archives: March 5, 2020

CME Exam 2: Getting to the Root of the Problem

Posted on March 5, 2020 by Gastroenterology
Posted in News | Comments Off on CME Exam 2: Getting to the Root of the Problem

Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy

Posted on March 5, 2020 by Gastroenterology Journal

Nucleic acid polymers (NAPs) inhibit assembly and secretion of hepatitis B virus (HBV) subviral particles. We performed an open-label, phase 2 study of the safety and efficacy of the NAPs REP 2139 or REP 2165 combined with tenofovir disoproxil fumarate… Continue reading →

Posted in News | Comments Off on Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy

CME Exam 4: Incidence of Venous Thromboembolism in Patients with Newly Diagnosed Pancreatic Cancer and Factors Associated with Outcomes

Posted on March 5, 2020 by Gastroenterology
Posted in News | Comments Off on CME Exam 4: Incidence of Venous Thromboembolism in Patients with Newly Diagnosed Pancreatic Cancer and Factors Associated with Outcomes

CME Exam 1: Use of Artificial Intelligence-Based Analytics From Live Colonoscopies to Optimize the Quality of the Colonoscopy Examination in Real Time: Proof of Concept

Posted on March 5, 2020 by Gastroenterology
Posted in News | Comments Off on CME Exam 1: Use of Artificial Intelligence-Based Analytics From Live Colonoscopies to Optimize the Quality of the Colonoscopy Examination in Real Time: Proof of Concept

CME Exam 3: Association Between Sulfur-Metabolizing Bacterial Communities in Stool and Risk of Distal Colorectal Cancer in Men

Posted on March 5, 2020 by Gastroenterology
Posted in News | Comments Off on CME Exam 3: Association Between Sulfur-Metabolizing Bacterial Communities in Stool and Risk of Distal Colorectal Cancer in Men